Result Type

You Searched For: Disodium+UDP-glucose

208  results were found

~~29188433AA Production of recombinant monoclonal an~~

1.0 0.9 0.8 0.7 0.6 0.5 rM A b (g /L ) 0.4 0.3 0.2 0.1 0 10 9 8 7 6 5 C el l d en si ty (c el ls /m L) 4 3 2 1 0 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Time (d) Feed Application note 29188433 AA GE Healthcare Production of recombinant monoclonal antib...

~~29188433AA Production of recombinant monoclonal an~~

1.0 0.9 0.8 0.7 0.6 0.5 rM A b (g /L ) 0.4 0.3 0.2 0.1 0 10 9 8 7 6 5 C el l d en si ty (c el ls /m L) 4 3 2 1 0 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Time (d) Feed Application note 29188433 AA GE Healthcare Production of recombinant monoclonal antib...

Açúcares e hidratos de carbono em conformidade com várias farmacopeias

Açúcares e hidratos de carbono em conformidade com várias farmacopeias Inovações Hidratos de carbono chave para bioprocessamento A produção biofarmacêutica utiliza frequentemente hidratos de carbono nas diferentes fases do processo nomeadamente na...

Zucker und Kohlenhydrate, die Anforderungen eines oder mehrerer Arzneibücher erfüllen

Zucker und Kohlenhydrate die Anforderungen eines oder mehrerer Arzneibücher erfüllen Innovationen Wichtige Kohlenhydrate für das Bioprocessing In der biopharmazeutischen Produktion werden Kohlenhydrate häufig in verschiedenen Stufen des Prozesses ...

~~29188433AA Production of recombinant monoclonal an~~

1.0 0.9 0.8 0.7 0.6 0.5 rM A b (g /L ) 0.4 0.3 0.2 0.1 0 10 9 8 7 6 5 C el l d en si ty (c el ls /m L) 4 3 2 1 0 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Time (d) Feed Application note 29188433 AA GE Healthcare Production of recombinant monoclonal antib...

Sucres et hydrates de carbone conformes à une ou plusieurs pharmacopées

Sucres et hydrates de carbone conformes à une ou plusieurs pharmacopées Innovations Principaux hydrates de carbone destinés à la biotransformation La production biopharmaceutique utilise régulièrement des hydrates de carbone à différentes étapes d...

Sanborn Manufacturing Facility

Sanborn Manufacturing Facility The HEPES manufacturing suite at our 60000 sq. ft. manufacturing facility in Sanborn NY USA. Core Capabilities Custom manufacturing of biological buffers amino acid derivatives and custom antibiotic solutions Industr...

Sanborn Manufacturing Facility

Sanborn Manufacturing Facility The HEPES manufacturing suite at our 60000 sq. ft. manufacturing facility in Sanborn NY USA. Core Capabilities Custom manufacturing of biological buffers amino acid derivatives and custom antibiotic solutions Industr...

Sanborn Manufacturing Facility

Sanborn Manufacturing Facility The HEPES manufacturing suite at our 60000 sq. ft. manufacturing facility in Sanborn NY USA. Core Capabilities Custom manufacturing of biological buffers amino acid derivatives and custom antibiotic solutions Industr...

Sanborn Manufacturing Facility

Sanborn Manufacturing Facility The HEPES manufacturing suite at our 60000 sq. ft. manufacturing facility in Sanborn NY USA. Core Capabilities Custom manufacturing of biological buffers amino acid derivatives and custom antibiotic solutions Industr...

Sugars and carbohydrates compendial and multi compendial

Sugars and carbohydrates compendial and multi compendial Innovations Key carbohydrates for bioprocessing Biopharmaceutical production often uses carbohydrates at different stages of the process notably fermentation cell culture or formulation. Ve...

Sugars and carbohydrates compendial and multi compendial

Sugars and carbohydrates compendial and multi compendial Innovations Key carbohydrates for bioprocessing Biopharmaceutical production often uses carbohydrates at different stages of the process notably fermentation cell culture or formulation. Ve...

Sugars and carbohydrates compendial and multi compendial

Sugars and carbohydrates compendial and multi compendial Innovations Key carbohydrates for bioprocessing Biopharmaceutical production often uses carbohydrates at different stages of the process notably fermentation cell culture or formulation. Ve...

Sanborn Manufacturing Facility

Sanborn Manufacturing Facility The HEPES manufacturing suite at our 60000 sq. ft. manufacturing facility in Sanborn NY USA. Core Capabilities Custom manufacturing of biological buffers amino acid derivatives and custom antibiotic solutions Industr...

Sanborn Manufacturing Facility

Sanborn Manufacturing Facility The HEPES manufacturing suite at our 60000 sq. ft. manufacturing facility in Sanborn NY USA. Core Capabilities Custom manufacturing of biological buffers amino acid derivatives and custom antibiotic solutions Industr...

~~29188433AA Production of recombinant monoclonal an~~

1.0 0.9 0.8 0.7 0.6 0.5 rM A b (g /L ) 0.4 0.3 0.2 0.1 0 10 9 8 7 6 5 C el l d en si ty (c el ls /m L) 4 3 2 1 0 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Time (d) Feed Application note 29188433 AA GE Healthcare Production of recombinant monoclonal antib...
65 - 80 of 208